NCT04460768

Who might be able to join this trial:

• You are a woman aged 18 or older
• You have been diagnosed with advanced ovarian cancer (known as stage III or IV) of a specific type called epithelial ovarian cancer (this includes several subtypes such as serous, mucinous, endometrioid, clear cell, or mixed types)
• Your diagnosis was made between January 2014 and December 2018
• At least 12 months of your health records are available from before your ovarian cancer diagnosis (these records do not need to be specifically about ovarian cancer)

Who may not be able to join:

• You took part in another clinical trial during the study period that tested a type of drug called a PARP inhibitor for treating advanced ovarian cancer
• Your ovarian cancer was diagnosed at an early stage (FIGO Stage I, IIA, IIB, or IIC)
• You have been diagnosed with another cancer in the past five years — though some exceptions may apply, such as certain skin cancers, early-stage cervical cancer, specific breast cancers where treatment finished more than three years ago with no return of the disease, or certain other cancers that were fully treated with no signs of return for five or more years (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.